The hematogenous and the ascending routes of infection are mainly discussed in the pathogenesis of pyelonephritis (PN). Animal experiments were initiated to study the efficiency of either route and the influence of additional factors, such as virulence of the infecting organisms, application of hormones, or mechanical lesion on the kidney. The ascending route of infection was not effective without additional facilitating factors, except for the E. coli O2 strain; due to application of hormones (estrogen, progesterone, prednisolone) PN occurred with serum resistant strains in a significant number of kidneys, but not with serum-sensitive strains. Medication of hormones or microtrauma (endovesical instillation of 1 ml of sterile saline) alone did not render the hematogenous route of infection effective, whereas the combination of both hormone and microtrauma resulted in a high incidence of renal infection. Ligature of the ureter made the kidneys equally susceptible to infection by both routes, irrespective of the virulence of the E. coli strain. It is concluded that in the pathogenesis of PN both the hematogenous and the ascending routes of infection are possible. The E. coli organisms will take the one pathway or the other depending on the infection facilitating factors that prevail in the individual case.

Keywords:
Coli pyelonephritis, Route of infection, E. coli pyelonephritis, hormonal induced, Estrogen, Hormone, Progesterone, Prednisolone, Facilitation of infection, Ligature of ureter
This content is only available via PDF.
© 1973 S. Karger AG, Basel
1973
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.